Skip to main content

2 Result(s)

within J. Hiragushi Remove this filter

and

  1. No Access

    Article

    The tumor-bearing state induces augmented responses of organ-associated lymphocytes to high-dose interleukin-2 therapy in mice

     A high-dose bolus regimen for interleukin(IL)-2 administration to cancer patients frequently causes serious side-effects in which various organs are involved. In order to reveal the mechanism of toxicities as...

    Y. Asano, K. Kaneda, J. Hiragushi, T. Tsuchida… in Cancer Immunology, Immunotherapy (1997)

  2. No Access

    Chapter and Conference Paper

    Therapeutic Strategy for Advanced Hepatocellular Carcinoma Using Systemic Interleukin-2 Infusion and Local Low-Dose Irradiation

    In two cases of unresectable HCC with multiple lesions, in which TAE was not indicated due to the vascular abnormality or allergy against iodide contrast medium, combination therapy with systemic low-dose IL-2...

    T. Tsuchida, Y. Asano, J. Hiragushi… in Recent Advances in Management of Digestive… (1993)